MARKET WIREYahoo Finance • 1d ago
Upcoming & Recent IPO's - IPOs CalendarYahoo Finance report covering Nordicus Partners Corporation (NORD) market action, institutional positioning, and fundamental catalysts.
Why NORD Stock dropped -25.08% Today — RQD Quant Desk Flash
$3.68 -25.08% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $3.51
Nordicus Partners Corporation (NORD) carries a Roarable Rating of D (Sell) with 45/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D • SELL / AVOID
Cap $95.5M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on NORD Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is NORD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Nordicus Partners Corporation (NASDAQ: NORD) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 45/100 at a spot price of $3.68 (-25.08% 1D, market cap $95.5M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 15/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 12/20, and Executive Insider Alignment 3/20. Across 1009 tracked Consumer Discretionary issuers, NORD ranks #661 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does NORD compare to RTB and TTEC in the Consumer Discretionary sector?
▼
Within the Consumer Discretionary sector (Professional Services), NORD carries a Roarable D (45/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -5.3%. By comparison, RTB (RTB Digital Inc.) holds a E grade (27/100 RQD, P/E N/A, ROIC -35.0%, cap $111.0M) and TTEC (TTEC Holdings Inc.) posts a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $78.4M). Among the 5-stock peer group, NORD leads on earnings multiple (N/A) while NORD leads on capital efficiency (-5.3% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for NORD?
▼
Per NORD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0001011060), Nordicus Partners Corporation generated $12.2M in revenue (+244675.9% YoY), -$4.0M in net income, and -$4.3M in free cash flow against $75.9M in total assets and $0 in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $3.51 (-4.70%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 5/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (45/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-6.3% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERSELL / AVOID • D
3-of-3 Quant Analysts Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR RQD RADARRw D- · Rk D+
Each axis scored 0–20
12M PRICE TARGET CONE-6% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for NORD)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (45/100 Composite)
🔍 WHY NORD SCORES 45/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+15/20 pts (33% of score)
20D Institutional Volume Accumulation (±12.5% realized swing band)
▲ #2 Bullish Driver: Macro Regime Fit+12/20 pts (27% of score)
FRED Regime × Technicals: 60% of 52W Range • RSI-14 at 66.7 (BULLISH MOMENTUM)
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade C-$4.00+0.5% Next Q
53
Q2 (-2Q)Grade C-$4.02-0.2% Next Q
50
Q3 (-1Q)Grade D$4.01-8.2% Next Q
48
CurrentGrade D$3.68-6.3% Hist 90D α
45
Trajectory: C- (53) → D (45)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a NORD Turnaround Squeeze
While NORD currently carries a cautious 45/100 (D) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Big institutional funds and options desks are actively positioning on the bullish side.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($3.91) and Max Pain ($3.86) forces dealer call-delta covering toward $5.41.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $NORD• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “NORD Beats Next Quarter EPS Consensus (Dec 29, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why NORD Stock dropped -25.08% Today — RQD Quant Desk Flash
Nordicus Partners Corporation (NORD) dropped -25.08% to $3.68, trading at 60% of its 52-week range ($1.48 – $5.15). Stretched risk/reward at current multiples (-5% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 60% of its 52-week range ($1.48 – $5.15) with RSI-14 at 66.7 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $3.68 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D (Sell) backed by 52% gross margin and $0 annual free cash flow.
Live NORD Headlines & Catalysts
CATALYSTMoomoo • 1d ago
Nordicus Partners Corporation Announces Uplisting to The Nasdaq Capital MarketMoomoo report covering Nordicus Partners Corporation (NORD) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStock Titan • 1d ago
A drug developer's shares are expected to start trading on Nasdaq Oct. 30.Stock Titan report covering Nordicus Partners Corporation (NORD) market action, institutional positioning, and fundamental catalysts.
CATALYSTwww.marketscreener.com • 1d ago
Nordicus Partners Corporation(NasdaqCM: NORD) added to NASDAQ Composite Indexwww.marketscreener.com report covering Nordicus Partners Corporation (NORD) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo Finance Singapore • 2d ago
Upcoming and recent IPOs – IPOs calendar – Yahoo FinanceYahoo Finance Singapore report covering Nordicus Partners Corporation (NORD) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStock Titan • 2d ago
A 46.88-cent dividend per depositary share from First Merchants is payable Nov. 16.Stock Titan report covering Nordicus Partners Corporation (NORD) market action, institutional positioning, and fundamental catalysts.
MARKET WIREBenzinga • 1d ago
12 Health Care Stocks Moving In Monday's Intraday SessionGainers Inovio Pharmaceuticals (NASDAQ:INO) shares rose 211.2% to $1.88 during Monday's regular session. The company's market cap stands at $62.2 million. BeyondSpring (NASDAQ:BYSI) stock moved upwards by
MARKET WIREBenzinga • 1d ago
12 Health Care Stocks Moving In Monday's Pre-Market SessionGainers Inovio Pharmaceuticals (NASDAQ:INO) shares increased by 232.0% to $2.0 during Monday's pre-market session. The company's market cap stands at $62.2 million. AngioDynamics (NASDAQ:ANGO) shares increased
CATALYSTBenzinga • 1d ago
Why Inovio Pharmaceuticals Shares Are Trading Higher By Over 230%; Here Are 20 Stocks Moving PremarketInovio shares surged 230% premarket after FDA accelerated Voceryq approval; ClearOne and 22nd Century gained, while RedCloud fell 33.5%.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring NORD)
- ✓Walkthrough of NORD's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
NORD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +3.37%▲ ASCENDING CHANNEL
2026-11-03O $5.09H $5.09L $3.68C $3.68VOL 98.0K
RES: $5.21SUP: $3.24SMA50: $3.91SMA200: $3.58
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
NORD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth
vs. +244675.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger
No active Ellis Vennor swing setup published on NORD today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for NORD. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for NORD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NORD)
Consumer Discretionary Rank #661 of 1009
⚔️ RTB vs NORD Full Matrix →
1. Head-to-Head Consumer Discretionary Peer Comparison (NORD vs. RTB, TTEC, MHH, EGG)
Industry: Professional Services (48 Tracked Issuers)Across 1009 tracked Consumer Discretionary securities in the Roarable RQD universe, Nordicus Partners Corporation (NORD) ranks #661 by composite RQD confidence (45/100, grade D) and #754 by equity capitalization ($95.5M). Within this direct 5-issuer industry benchmark cohort, NORD leads on earnings valuation at N/A trailing P/E, while NORD leads on capital efficiency and profitability with -5.3% ROIC and — gross margin. MHH currently holds the highest overall quantitative score in the immediate peer group at 53/100 (D+) compared with NORD at 45/100 (D).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| NORD
ACTIVE
Nordicus Partners Corporation | D | 45/100 | — | — | -5.3% | -25.08% | $95.5M | Benchmark Subject |
| RTB RTB Digital Inc. | E | 27/100 | — | 47.7% | -35.0% | -4.18% | $111.0M | /rtb-vs-nord → |
| TTEC TTEC Holdings Inc. | D- | 38/100 | — | — | -35.0% | -1.89% | $78.4M | /ttec-vs-nord → |
| MHH Mastech Digital Inc | D+ | 53/100 | — | 27.7% | 0.0% | +3.50% | $75.4M | /mhh-vs-nord → |
| EGG Enigmatig Limited (Class A) | D- | 40/100 | — | 68.8% | — | +0.67% | $136.7M | /egg-vs-nord → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2026-03-31 • CIK 0001011060 ↗In its most recent audited fiscal period (FY2025, filed 2026-03-31), Nordicus Partners Corporation (NORD) reported GAAP revenue of $12.2M (+244675.9% vs. FY2024 revenue of $5.0K , and +489451.8% cumulative change since FY2023) , GAAP net income of -$4.0M, operating cash flow of -$4.3M, and free cash flow of -$4.3M (-238.0% YoY). On the balance sheet, NORD closed FY2025 with $75.9M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 1/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2026-03-31 | $12.2M | -$4.0M | -$4.3M | -$4.3M | $75.9M | — |
| FY2024 (FY) | 2025-03-31 | $5.0K | -$2.9M | -$1.3M | -$1.3M | $59.7M | — |
| FY2023 (FY) | 2024-03-31 | $2.5K | -$298.2K | -$258.9K | -$258.9K | — | — |
3. NORD Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs NORD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Nordicus Partners Corporation (NASDAQ: NORD) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 45/100 at a spot price of $3.68 (-25.08% 1D, market cap $95.5M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 15/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 12/20, and Executive Insider Alignment 3/20. Across 1009 tracked Consumer Discretionary issuers, NORD ranks #661 in composite RQD confidence.
How does NORD compare to RTB and TTEC in the Consumer Discretionary sector?
Within the Consumer Discretionary sector (Professional Services), NORD carries a Roarable D (45/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -5.3%. By comparison, RTB (RTB Digital Inc.) holds a E grade (27/100 RQD, P/E N/A, ROIC -35.0%, cap $111.0M) and TTEC (TTEC Holdings Inc.) posts a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $78.4M). Among the 5-stock peer group, NORD leads on earnings multiple (N/A) while NORD leads on capital efficiency (-5.3% ROIC).
What are the biggest fundamental strengths and SEC risk factors for NORD?
Per NORD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0001011060), Nordicus Partners Corporation generated $12.2M in revenue (+244675.9% YoY), -$4.0M in net income, and -$4.3M in free cash flow against $75.9M in total assets and $0 in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
Where is NORD trading relative to its 50-day, 200-day, and 52-week technical levels?
NORD last traded at $3.68 (-25.08% on volume of 35,801 shares), positioning the stock -5.88% below its 50-day simple moving average ($3.91) and +2.79% above its 200-day simple moving average ($3.58). Across its 52-week range of $1.48 to $5.15, NORD sits at the 59.9% percentile with a 14-day RSI of 66.7 (BULLISH MOMENTUM) and an implied next-earnings move of ±12.5% ($3.22 to $4.14).
ROARABLE RATING BRIEF • RQD 45/100 (D)
✓ SEC XBRL & RQD VERIFIED
NORD — Nordicus Partners Corporation: What the Facts Mean to a Prospective Investor
Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2026-03-31
1. Roarable Rating Brief: What This Means to a Prospective Investor
Nordicus Partners Corporation (NORD) earns a live Roarable RQD composite score of 45/100, corresponding to a D letter grade (Roarable Sell) at a spot price of $3.68 (-25.08% 1D, market capitalization $95.5M).
- Fundamental Cash Engine (5/20): Anchored by return on invested capital (ROIC) of -5.3%, gross margin of —, operating margin of —, and free cash flow yield of -0.82%.
- Whale 13F & Options Flow (15/20) + Insider Conviction (3/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (12/20) + Forensic Balance Sheet (10/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 1/9, and Debt/Equity of N/A.
2. Business Model, Unit Margins & SEC Financial Trajectory
Sector: Consumer Discretionary. Industry: Professional Services. Exchange: NASDAQ. Is a NASDAQ-listed issuer operating in Professional Services.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2026-03-31), Nordicus Partners Corporation (NORD) reported $12.2M in annual revenue (up from $5.0K in FY2024, +244675.9% YoY) and -$4.0M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($2.5K revenue, -$298.2K net income) through FY2025, NORD scaled operating cash flow to -$4.3M and free cash flow to -$4.3M, backed by $75.9M in total assets against $0 in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (D • RQD 45/100): Big institutional funds and options desks are actively positioning on the bullish side. Free cash flow yield of -0.82% and institutional whale pillar of 15/20. With Fundamental Cash Engine at 5/20 and Institutional Whale Flow at 15/20, sustained execution supports upside toward the upper end of the $1.48 – $5.15 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against — operating margins and a 1.00x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
The only sector context is the classification as Consumer Discretionary / Professional Services, with Beta of 1.0 per the market data.
- Key Question #1: Can NORD sustain or expand its — operating margin and -5.3% ROIC against Professional Services peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $12.2M and free cash flow of -$4.3M, how will capital allocation balance growth reinvestment against $0 in total debt?
- Key Question #3: How sensitive is NORD's equity valuation to Consumer Discretionary capital spending cycles and macro interest-rate shifts (Beta 1.00x)?
NORD Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Nordicus Partners Corporation (NORD) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Yahoo Finance • 1d ago
Upcoming & Recent IPO's - IPOs Calendar Yahoo Finance report covering Nordicus Partners Corporation (NORD) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST Moomoo • 1d ago
Nordicus Partners Corporation Announces Uplisting to The Nasdaq Capital Market Moomoo report covering Nordicus Partners Corporation (NORD) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Titan • 1d ago
A drug developer's shares are expected to start trading on Nasdaq Oct. 30. Stock Titan report covering Nordicus Partners Corporation (NORD) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST www.marketscreener.com • 1d ago
Nordicus Partners Corporation(NasdaqCM: NORD) added to NASDAQ Composite Index www.marketscreener.com report covering Nordicus Partners Corporation (NORD) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance Singapore • 2d ago
Upcoming and recent IPOs – IPOs calendar – Yahoo Finance Yahoo Finance Singapore report covering Nordicus Partners Corporation (NORD) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Titan • 2d ago
A 46.88-cent dividend per depositary share from First Merchants is payable Nov. 16. Stock Titan report covering Nordicus Partners Corporation (NORD) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Benzinga • 1d ago
12 Health Care Stocks Moving In Monday's Intraday Session Gainers Inovio Pharmaceuticals (NASDAQ:INO) shares rose 211.2% to $1.88 during Monday's regular session. The company's market cap stands at $62.2 million. BeyondSpring (NASDAQ:BYSI) stock moved upwards by
🟡 MARKET WIRE Benzinga • 1d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Inovio Pharmaceuticals (NASDAQ:INO) shares increased by 232.0% to $2.0 during Monday's pre-market session. The company's market cap stands at $62.2 million. AngioDynamics (NASDAQ:ANGO) shares increased
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
NORD Bull vs. Bear Conversation Board — What's Your Call at $3.68?
🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON NORD 🐻 33% BEARISH CONVICTION
MI MidwestValue RQD DEBATE OPENER • Fundamental Long-Only 🐂 BULLISH
🎯 Target: $6.04 (+23.0%)
📌 Pinned Debate Institutional accumulation (Whale 13F Flow 15/20) and a 27.12% price change alongside the Nasdaq Capital Market uplisting and Composite
The street is overcomplicating Nordicus Partners Corporation (NORD). Institutional accumulation (Whale 13F Flow 15/20) and a 27.12% price change alongside the Nasdaq Capital Market uplisting and Composite Index addition.. With an RQD score of 45/100 (D) and Forensic Balance Sheet at 10/20, any positive earnings surprise or guidance raise forces underweight funds to chase above $5.30.
EarningsSniper 🐂 BULL
Both sides have a point here — NORD's 10/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.
FA FadeTheHype RQD DEBATE OPENER • Contrarian Tape Reader 🐻 BEARISH
🎯 Target: $3.78 (-23.0%)
Spot @ $4.91 Negative ROIC of -5.3%, FCF yield of -0.82%, and $0.0M reported revenue leave the Fundamental Cash Engine pillar at only 5/20.
I respect the product at Nordicus Partners Corporation, but the stock at $4.91 is a different story. Negative ROIC of -5.3%, FCF yield of -0.82%, and $0.0M reported revenue leave the Fundamental Cash Engine pillar at only 5/20.. FCF yield is -0.82% and RQD sits at 45/100 (D) — why pay up here when you can wait for next quarter's numbers?